T2 Biosystems Newsroom

T2 Biosystems: Hold Rating Maintained Amid Growth Prospects and Profitability Concerns

TipRanksMay 7 07:55 ET

T2 Biosystems Analyst Ratings

BenzingaApr 29 10:42 ET

Alliance Global Partners Maintains Neutral on T2 Biosystems, Lowers Price Target to $0.07

BenzingaJul 13, 2023 10:38 ET

T2 Biosystems Analyst Ratings

BenzingaJul 13, 2023 10:37 ET

T2 Biosystems (TTOO) Receives a Hold From BTIG

TipRanksMay 23, 2023 20:55 ET

Alliance Global Adjusts Price Target on T2 Biosystems to $1.50 From $2.20, Maintains Neutral Rating

MT NewswiresJan 24, 2023 09:16 ET

T2 Biosystems Analyst Ratings

Benzinga Analyst RatingsJan 24, 2023 08:08 ET

Alliance Global Partners Maintains Neutral on T2 Biosystems, Lowers Price Target to $1.5

Benzinga Real-time NewsJan 24, 2023 08:08 ET

BTIG Keeps Their Hold Rating on T2 Biosystems (TTOO)

TipRanksNov 13, 2022 23:10 ET

Analysts Offer Insights on Healthcare Companies: T2 Biosystems (TTOO) and Axsome Therapeutics (AXSM)

TipRanksOct 14, 2022 08:45 ET

T2 Biosystems Analyst Ratings

Benzinga Analyst RatingsOct 14, 2022 04:57 ET

Canaccord Genuity Downgrades T2 Biosystems to Hold, Adjusts Price Target to $2.5

Benzinga Real-time NewsOct 14, 2022 04:56 ET

Analysts Offer Insights on Healthcare Companies: T2 Biosystems (TTOO), Poseida Therapeutics (PSTX) and COMPASS Pathways (CMPS)

TipRanksOct 14, 2022 00:50 ET

BTIG Reaffirms Their Hold Rating on T2 Biosystems (TTOO)

TipRanksAug 23, 2022 00:50 ET

T2 Biosystems Cut to Neutral From Buy by Alliance Global Partners

Dow JonesJul 7, 2022 12:18 ET

BTIG Downgrades T2 Biosystems to Neutral from Buy, Lowers Price Target to $0.14 From $0.65

MT NewswiresJul 7, 2022 10:28 ET

T2 Biosystems Cut to Neutral From Buy by BTIG

Dow JonesJul 7, 2022 07:35 ET

T2 Biosystems analyst ratings

Benzinga Analyst RatingsJul 7, 2022 07:26 ET